Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 871576, 14 pages
http://dx.doi.org/10.1155/2014/871576
Research Article

Insight into HIV of IFN-Induced Myxovirus Resistance 2 (MX2) Expressed by Traditional Chinese Medicine

1Department of Biomedical Informatics, Asia University, Taichung 41354, Taiwan
2School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Neurosurgery, China Medical University Hospital, No. 2 Yude Road, North District, Taichung 40447, Taiwan
4Department of Anesthesiology, China Medical University Hospital, Taichung 40447, Taiwan
5Research Center for Chinese Medicine & Acupuncture, China Medical University, Taichung 40402, Taiwan
6Human Genetic Center, Department of Medical Research, China Medical University Hospital, Taichung 40447, Taiwan

Received 24 February 2014; Revised 5 March 2014; Accepted 5 March 2014; Published 18 June 2014

Academic Editor: Chung Y. Hsu

Copyright © 2014 Tzu-Chieh Hung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Barre-Sinoussi, J. C. Chermann, F. Rey et al., “Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS),” Science, vol. 220, no. 4599, pp. 868–871, 1983. View at Google Scholar · View at Scopus
  2. M. W. Cloyd, J. J. Y. Chen, and L. Q. Wang, “How does HIV cause AIDS? The homing theory,” Molecular Medicine Today, vol. 6, no. 3, pp. 108–111, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Weiss, “How does HIV cause AIDS?” Science, vol. 260, no. 5112, pp. 1273–1279, 1993. View at Google Scholar · View at Scopus
  4. D. C. Douek, M. Roederer, and R. A. Koup, “Emerging concepts in the immunopathogenesis of AIDS,” Annual Review of Medicine, vol. 60, pp. 471–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Weller and K. Davis, “Condom effectiveness in reducing heterosexual HIV transmission,” The Cochrane Database of Systematic Reviews, no. 1, Article ID CD003255, 2002. View at Google Scholar · View at Scopus
  6. B. Leynaert, A. M. Downs, and I. de Vincenzi, “Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection,” The American Journal of Epidemiology, vol. 148, no. 1, pp. 88–96, 1998. View at Google Scholar · View at Scopus
  7. D. M. Bell, “Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview,” The American Journal of Medicine, vol. 102, no. 5, pp. 9–15, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Cleveland, L. Barker, B. F. Gooch, E. M. Beltrami, and D. Cardo, “Use of HIV postexposure prophylaxis by dental health care personnel: an overview and updated recommendations,” Journal of the American Dental Association, vol. 133, no. 12, pp. 1619–1626, 2002. View at Google Scholar · View at Scopus
  9. J. C. Forbes, A. M. Alimenti, J. Singer et al., “A national review of vertical HIV transmission,” AIDS, vol. 26, no. 6, pp. 757–763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. M. Little, P. H. Kilmarx, A. W. Taylor, C. E. Rose, E. D. Rivadeneira, and S. R. Nesheim, “A review of evidence for transmission of HIV from children to breastfeeding women and implications for prevention,” The Pediatric Infectious Disease Journal, vol. 31, no. 9, pp. 938–942, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Finzi, M. Hermankova, T. Pierson et al., “Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy,” Science, vol. 278, no. 5341, pp. 1295–1300, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Goujon, O. Moncorge, H. Bauby et al., “Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection,” Nature, vol. 502, no. 7472, pp. 559–562, 2013. View at Publisher · View at Google Scholar
  13. J. W. Schoggins, S. J. Wilson, M. Panis et al., “A diverse range of gene products are effectors of the type I interferon antiviral response,” Nature, vol. 472, no. 7344, pp. 481–485, 2011. View at Publisher · View at Google Scholar
  14. H.-J. Huang, H. W. Yu, C.-Y. Chen et al., “Current developments of computer-aided drug design,” Journal of the Taiwan Institute of Chemical Engineers, vol. 41, no. 6, pp. 623–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. W. I. Tou, S. S. Chang, C. C. Lee, and C. Y. Chen, “Drug design for neuropathic pain regulation from traditional Chinese medicine,” Scientific Reports, vol. 3, p. 844, 2013. View at Google Scholar · View at Scopus
  16. C. Y. Chen, “A novel integrated framework and improved methodology of computer-aided drug design,” Current Topics in Medicinal Chemistry, vol. 13, no. 9, pp. 965–988, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Y.-C. Chen and W. I. Tou, “How to design a drug for the disordered proteins?” Drug Discovery Today, vol. 18, no. 19-20, pp. 910–915, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. S. C. Basak, “Recent developments and future directions at current computer aided drug design,” Current Computer-Aided Drug Design, vol. 9, no. 1, p. 1, 2013. View at Google Scholar · View at Scopus
  19. C. Y. Chen, “Weighted equation and rules—a novel concept for evaluating protein-ligand interaction,” Journal of Biomolecular Structure and Dynamics, vol. 27, no. 3, pp. 271–282, 2009. View at Google Scholar · View at Scopus
  20. W.-L. Liao and F.-J. Tsai, “Personalized medicine: a paradigm shift in healthcare,” BioMedicine, vol. 3, no. 2, pp. 66–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Lee -, C. Tsai -H, L. Wan et al., “Increased incidence of Parkinsonism among Chinese with β-glucosidase mutation in central Taiwan,” BioMedicine, vol. 3, no. 2, pp. 92–94, 2013. View at Publisher · View at Google Scholar
  22. I. C. Chou, W. Lin -D, C. Wang -H et al., “Möbius syndrome in a male with XX/XY mosaicism,” BioMedicine, vol. 3, no. 2, pp. 102–104, 2013. View at Publisher · View at Google Scholar
  23. C. Y. Chen, “TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. J. Huang, K. J. Lee, H. W. Yu et al., “Structure-based and ligand-based drug design for HER 2 receptor,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 1, pp. 23–37, 2010. View at Google Scholar · View at Scopus
  25. W. I. Tou and C. Y. Chen, “Traditional Chinese medicine as dual guardians against hypertension and cancer?” Journal of Biomolecular Structure and Dynamics, vol. 30, no. 3, pp. 299–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. C. Yang, S. S. Chang, and C. Y. Chen, “Identifying HER2 inhibitors from natural products database,” PLoS ONE, vol. 6, no. 12, Article ID e28793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Y. Chen and C. Y. Chen, “Insights into designing the dual-targeted HER2/HSP90 inhibitors,” Journal of Molecular Graphics and Modelling, vol. 29, no. 1, pp. 21–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. S. Chang, H. J. Huang, and C. Y. Chen, “High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan,” Molecular BioSystems, vol. 7, no. 12, pp. 3366–3374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. H. Lin, T. T. Chang, M. F. Sun et al., “Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database,” Journal of Biomolecular Structure and Dynamics, vol. 28, no. 4, pp. 471–482, 2011. View at Google Scholar · View at Scopus
  30. S. S. Chang, H. J. Huang, and C. Y. Chen, “Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine,” PLoS Computational Biology, vol. 7, no. 12, Article ID e1002315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Y. Chen, Y. H. Chang, D. T. Bau et al., “Ligand-based dual target drug design for H1N1: swine flu—a preliminary first study,” Journal of Biomolecular Structure and Dynamics, vol. 27, no. 2, pp. 171–178, 2009. View at Google Scholar · View at Scopus
  32. H. J. Huang, Y. R. Jian, and C. Y. Chen, “Traditional Chinese medicine application in HIV: an in silico study,” Journal of Biomolecular Structure and Dynamics, vol. 32, no. 1, pp. 1–12, 2014. View at Google Scholar
  33. T. Y. Tsai, K. W. Chang, and C. Y. Chen, “IScreen: world's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. K. W. Chang, T. Y. Tsai, K. C. Chen et al., “iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design,” Journal of Biomolecular Structure and Dynamics, vol. 29, no. 1, pp. 243–250, 2011. View at Google Scholar · View at Scopus
  35. Y. Zhang, “I-TASSER server for protein 3D structure prediction,” BMC Bioinformatics, vol. 9, article 40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. B. Xue, R. L. Dunbrack, R. W. Williams, A. K. Dunker, and V. N. Uversky, “PONDR-FIT: a meta-predictor of intrinsically disordered amino acids,” Biochimica et Biophysica Acta, vol. 1804, no. 4, pp. 996–1010, 2010. View at Google Scholar
  37. W. I. Tou and C. Y. Chen, “May disordered protein cause serious drug side effect?” Drug Discovery Today, vol. 19, no. 4, pp. 367–372, 2013. View at Google Scholar
  38. C. M. Venkatachalam, X. Jiang, T. Oldfield, and M. Waldman, “LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites,” Journal of Molecular Graphics and Modelling, vol. 21, no. 4, pp. 289–307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. B. R. Brooks, C. L. Brooks III, A. D. Mackerell Jr. et al., “CHARMM: the biomolecular simulation program,” Journal of Computational Chemistry, vol. 30, no. 10, pp. 1545–1614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. R. A. Laskowski and M. B. Swindells, “LigPlot+: multiple ligand-protein interaction diagrams for drug discovery,” Journal of Chemical Information and Modeling, vol. 51, no. 10, pp. 2778–2786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. C. Wallace, R. A. Laskowski, and J. M. Thornton, “LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions,” Protein Engineering, vol. 8, no. 2, pp. 127–134, 1995. View at Google Scholar · View at Scopus
  42. U. D. Priyakumar and A. D. MacKerell, “Comparison of the CHARMM27, AMBER4.1 and BMS nucleic acid force fields via free energy calculations of base flipping,” Abstracts of Papers of the American Chemical Society, vol. 230, pp. U1391–U1392, 2005. View at Google Scholar
  43. B. Hess, C. Kutzner, D. van der Spoel, and E. Lindahl, “GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation,” Journal of Chemical Theory and Computation, vol. 4, no. 3, pp. 435–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Zoete, M. A. Cuendet, A. Grosdidier, and O. Michielin, “SwissParam: a fast force field generation tool for small organic molecules,” Journal of Computational Chemistry, vol. 32, no. 11, pp. 2359–2368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. T. A. Darden and L. G. Pedersen, “Molecular modeling: an experimental tool,” Environmental Health Perspectives, vol. 101, no. 5, pp. 410–412, 1993. View at Google Scholar · View at Scopus
  46. M. Yoshikawa, S. Hatakeyama, Y. Inoue, and J. Yamahara, “Saussureamines A, B, C, D, and E, new anti-ulcer principles from Chinese Saussureae radix,” Chemical and Pharmaceutical Bulletin, vol. 41, no. 1, pp. 214–216, 1993. View at Google Scholar · View at Scopus
  47. Y. K. Choi, S. G. Cho, S. M. Woo et al., “Saussurea lappa clarke-derived costunolide prevents TNF alpha -induced breast cancer cell migration and invasion by inhibiting NF- kappa B activity,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 936257, 10 pages, 2013. View at Publisher · View at Google Scholar
  48. O. P. Upadhyay, J. K. Ojha, H. S. Bajpai, and A. K. Hathwal, “Study of kustha (Saussurea lappa, Clarke) in ischaemic heart disease,” Ancient Science of Life, vol. 13, no. 1-2, pp. 11–18, 1993. View at Google Scholar
  49. T. S. Saleem, N. Lokanath, A. Prasanthi, M. Madhavi, G. Mallika, and M. N. Vishnu, “Aqueous extract of Saussurea lappa root ameliorate oxidative myocardial injury induced by isoproterenol in rats,” Journal of Advanced Pharmaceutical Technology and Research, vol. 4, no. 2, pp. 94–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Yaeesh, Q. Jamal, A. J. Shah, and A. H. Gilani, “Antihepatotoxic activity of Saussurea lappa extract on D-galactosamine and lipopolysaccharide-induced hepatitis in mice,” Phytotherapy Research, vol. 24, supplement 2, pp. S229–S232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Taniguchi, T. Kattaoka, H. Suzuki et al., “Costunolide and dehydrocostus lactone as inhibitors of killing function of cytotoxic T lymphocytes,” Bioscience, Biotechnology and Biochemistry, vol. 59, no. 11, pp. 2064–2067, 1995. View at Google Scholar · View at Scopus
  52. Y. Hata, S. N. Ebrahimi, and M. De Mieri, “Antitrypanosomal isoflavan quinones from Abrus precatorius,” Fitoterapia, vol. 93, pp. 81–87, 2014. View at Publisher · View at Google Scholar
  53. Y. Hata, M. Raith, S. N. Ebrahimi et al., “Antiprotozoal isoflavan quinones from Abrus precatorius ssp. africanus,” Planta Medica, vol. 79, no. 6, pp. 492–498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. O. Adelowotan, I. Aibinu, E. Adenipekun, and T. Odugbemi, “The in-vitro antimicrobial activity of Abrus precatorius (L) fabaceae extract on some clinical pathogens,” The Nigerian Postgraduate Medical Journal, vol. 15, no. 1, pp. 32–37, 2008. View at Google Scholar · View at Scopus
  55. A. A. Rahman, V. Samoylenko, S. K. Jain et al., “Antiparasitic and antimicrobial isoflavanquinones from Abrus schimperi,” Natural Product Communications, vol. 6, no. 11, pp. 1645–1650, 2011. View at Google Scholar · View at Scopus
  56. V. Jayakumar, R. Bhaskaran, and S. Tsushima, “Potential of plant extracts in combination with bacterial antagonist treatment as biocontrol agent of red rot of sugarcane,” Canadian Journal of Microbiology, vol. 53, no. 2, pp. 196–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. S. C. Kuo, S. C. Chen, L. H. Chen, J. B. Wu, J. P. Wang, and C. M. Teng, “Potent antiplatelet, anti-inflammatory and antiallergic isoflavanquinones from the roots of Abrus precatorius,” Planta Medica, vol. 61, no. 4, pp. 307–312, 1995. View at Publisher · View at Google Scholar · View at Scopus
  58. N. Saxena, P. Yadav, and O. Kumar, “The Fas/Fas ligand apoptotic pathway is involved in abrin-induced apoptosis,” Toxicological Sciences, vol. 135, no. 1, pp. 103–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Shafi Sofi, M. K. Sateesh, M. Bashir et al., “Cytotoxic and pro-apoptotic effects of Abrus precatorius L. on human metastatic breast cancer cell line, MDA-MB-231,” Cytotechnology, vol. 65, no. 3, pp. 407–417, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Gadadhar and A. A. Karande, “Abrin immunotoxin: targeted cytotoxicity and intracellular trafficking pathway,” PLoS ONE, vol. 8, no. 3, Article ID e58304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. S.C. Lovell, L. W. Davis, W. B. Arendall III et al., “Structure validation by Cα geometry: ϕ, ψ and Cβ deviation,” Proteins: Structure, Function, and Bioinformatics, vol. 50, no. 3, pp. 437–450, 2003. View at Publisher · View at Google Scholar